Biotech

All Articles

A closer check out Fierce Biotech's Strong 15

.In this week's episode of "The Leading Pipe," we're diving in to Tough Biotech's yearly Tough 15 sp...

Lilly faces phase 2 failure of tau-targeting med

.The confetti is actually still soaring from Eli Lilly's gathering commemorating the commendation of...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings a...

Lykos will definitely inquire FDA to reexamine its own decision adhering to being rejected of MDMA therapy for post-traumatic stress disorder

.Observing an inadequate showing for Lykos Therapies' MDMA candidate for post-traumatic stress disor...

AN 2 one-halfs roll call, ceases period 3 trial after information disappoint

.AN2 Rehabs is reassessing its business in action to uninspired midphase data, promising to lay off ...

Merck pays $700M for bispecific, snooping autoimmune opening and also opportunity to test Amgen in cancer

.Merck &amp Co. is actually paying for $700 thousand beforehand to challenge Amgen in a blood stream...

Gilead pays J&ampJ $320M to leave licensing bargain for seladelpar

.Along With Gilead Sciences almost an FDA choice for its liver disease drug seladelpar, the provider...

' All hands on deck' at Lilly as peers target weight problems market

.Chief executive officer David Ricks may see the companies putting together outdoors tents at baseca...

Entero giving up team, vacating workplace as well as stopping R&ampD

.Bed mattress Liquidators has turned Entero Rehabs white colored as a slab. The collector ordered En...

Exelixis loses ADC after determining it's no suit for Tivdak

.Exelixis is quiting on its own cells element (TF)- targeting antibody-drug conjugate after ending t...